News and Comments

OSI (OSIP): Congratulation Prohost Subscribers. A Take Over with over 40% Premium.

  Monday, March 01, 2010

OSI (OSIP): Congratulation Prohost Subscribers. A Take Over with over 40% Premium.  More...


Recent Postings


Archive


Tags

ZALTRAP™ Intrexon (XON) Intercept (ICPT) Merck (MRK) KERYX (KERX) PORTOLA (PTLA) BIOMARIN (BMRN) Sanofi (SNA) Revlimid (lenolidamide) GUARDIAN HEALTH AstraZeneca (AZN) Roche (ROCHE) Ridaforolimus GlaxoSmithKline (GSK) INNOVIVA (INVA) Abbott Laboratories (ABT) Genentech MODERNA Pluristem (PSTI) Bristol-Myers Squibb (BMY) Inovio (INO) Valeant Pharmaceuticals International (VRX) Intermune (ITMN) Theravance Bio Pharma (TBPH) Idenix (IDIX) ImmunoGen (IMGN) Ariad (ARIA) IDERA (IDRA) Agenus (AGEN Benlysta (belimumab) Human Longevity (HLI) Regeneron (REGN) Jazz Pharmaceuticals (JAZZ) REGULUS (RGLS) ADVENTRIX (ANX) Ocular Therapeutix (OCUL) Incyte (INCY) Biogen Idec (BIIB) JUNO (JUNO) C4 Therapeutics CompuGen (CGEN) ACADIA (ACAD) AERIE PHARMACEUTICALS Auspex (ASPX) Herceptin VANDA (VNDA) AGOS (ARGS) ABBVIE (ABBV) Adaptimmune (ADAP) KITE (KITE) Anacor (ANAC) Spike Therapeutics (ONCE) NOVOCURE (NVCR) Array Pharmaceuticals (ARRY) SUNESIS PHARMACEUTICALS (SNSS) Bellicum (BLCM) NANTKWEST (NK) Cytokinetics (CYTK) Rapamune SYNTA (SNTA) Anadys (ANDS) Micromet (MITI) Gilead (GILD) SERES THERAPEUTICS (MCRB) Tysabri Ziofpharm (ZIOP) Exelixis (EXEL) Prolor Biotech (PBTH) Multiple Myeloma Editas (EDIT) Alder Biopharmaceuticals (ALDR) JOUNCE THERAPEUTICS (JNCE) Endometrial Cancer Sanofi (SNY) HALOZYME (HALO) Velcade (bortezomib) Mirati Therapeutics (MRTX) Xoma (XOMA) ARGOS (ARGS) ISIS (ISIS) Dynavax (DVAX) Agenus (AGEN) OSI (OSIP) Vertex (VRTX) Sangamo (SGMO) Sanofi-Aventis (SAN) Galena (GALE) Sequenom (SQNM) Sarepta (SRPT) CEMPRA (CEMP) Zerenex Illumina (ILMN) ARCA (ABIO) Seattle Genetics (SGEN) Telaprevir galapagos (GLPG) PTC Therapeutics (PTCT) Ionis (IONS) Advaxis (ADXS) NEKTAR (NKTR)) Dendreon (DNDN) Amgen (AMGN) TOKAI (TKAOI) Theravance (THRX) Human Genome Sciences (HGSI) Roche (RHHBY) Prosensa (RNA) CRISPR Therapeutics (CRSP) Elan (ELN) Alnylam (ALNY) Biocryst (BCRX) RenenxBio (RGNX) Trastuzumab-DM1 Vitae Pharmaceuticals (VTAE) Global Cell Therapeutics (GBT) Onyx (ONXX) Aimmune Therapeutics (AIMT)